Translating cGMP analogues into a treatment for retinitis pigmentosa

Description of the granted funding

Inherited retinal degenerations, such as retinitis pigmentosa, cause loss of vision already at young age, because there is no cure to these diseases. In this project, new medication is being developed for the treatment of retinitis pigmentosa. The project aims to generate pre-clinical data that supports translation of the new medications to clinical studies. The role of University of Eastern Finland in this European project is related to formulation of the new compounds in nanostructures to reach targeted and prolonged drug activity.
Show more

Starting year

2021

End year

2024

Granted funding

Arto Urtti Orcid -palvelun logo
272 383 €

Funder

Research Council of Finland

Funding instrument

Kansainvälinen yhteisrahoitteinen ohjelma

Other information

Funding decision number

344718

Fields of science

Biomedicine

Research fields

Biolääketieteet

Identified topics

eyes, eye diseases